Expression and function of Fas antigen on activated murine B cells. (Q54154390)

25 May 2018

title

Expression and function of Fas antigen on activated murine B cells. (English)

1 reference

25 May 2018

author

Yoichi Maekawa

3

1 reference

25 May 2018

author name string

Wang J

1

1 reference

25 May 2018

Taniuchi I

2

1 reference

25 May 2018

Howard M

4

1 reference

25 May 2018

Cooper MD

5

1 reference

25 May 2018

Watanabe T

6

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 January 1996

1 reference

25 May 2018

European Journal of Immunology

published in

1 reference

25 May 2018

volume

26

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

92-96

1 reference

25 May 2018

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Mechanism of antigen-driven selection in germinal centres

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Rescue from anti‐IgM‐induced programmed cell death by the B cell surface proteins CD20 and CD40

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Humoral immune responses in CD40 ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260114

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260114

1 reference

25 May 2018

PubMed ID

8566089

1 reference

25 May 2018